A detailed history of Pinpoint Asset Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Pinpoint Asset Management LTD holds 9,745 shares of MRNA stock, worth $519,311. This represents 0.23% of its overall portfolio holdings.

Number of Shares
9,745
Previous 4,889 99.33%
Holding current value
$519,311
Previous $520,000 122.5%
% of portfolio
0.23%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $491,475 - $809,058
4,856 Added 99.33%
9,745 $1.16 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $417,373 - $564,386
4,889 New
4,889 $520,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pinpoint Asset Management LTD Portfolio

Follow Pinpoint Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinpoint Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinpoint Asset Management LTD with notifications on news.